When Should Disease-Modifying Treatment Start for RRMS?

Getting a diagnosis of relapsing-remitting multiple sclerosis (RRMS) can feel overwhelming, and deciding when to start long-term immune treatment is a major step. Generally, neurologists recommend beginning a discussion about disease-modifying therapy (DMT) promptly after an active RRMS diagnosis is confirmed. While there is no need to rush into a first dose tomorrow—you should take time to understand your options, complete pre-treatment testing, and update vaccines—deliberately waiting for more relapses to occur is usually discouraged. Observational studies consistently link earlier treatment to a lower risk of accumulating long-term physical disability ^{[1] [2]}.

The First Step: Confirming Your Diagnosis

Before starting a long-term DMT, your neurologist will carefully apply formal diagnostic criteria to ensure the diagnosis is definitively MS.

• Clinically Isolated Syndrome (CIS): If you have only experienced a single neurological event, this is known as CIS. Depending on your MRI and risk factors, your care team may recommend a “wait and see” approach, or they may recommend selective treatment if your risk of developing MS is high ^{[3] [4]}.
• Established RRMS: To confirm RRMS, your doctor looks for evidence that the disease has affected multiple parts of the central nervous system at different times (dissemination in space and time) ^[5]. No single symptom or test can diagnose MS on its own. For instance, oligoclonal bands (OCBs)—proteins found in the spinal fluid that indicate immune activity—can help satisfy part of the diagnostic criteria in some situations, but they are not proof of MS by themselves ^[5].
• Ruling out mimics: Your doctor will also ensure that conditions that mimic MS, such as certain vascular issues or other autoimmune diseases, have been ruled out ^{[6] [5]}.

The Goals and Benefits of Early Treatment

MS activity can occur without noticeable symptoms and may appear only on follow-up MRI scans. DMTs are designed to reduce future relapses and prevent new MRI lesions; they do not reverse existing damage or guarantee that disability will not develop ^[7].

• Slowing disability: Observational studies show that starting treatment early is linked to a slower accumulation of physical disability compared to delaying treatment by a few years ^{[1] [2]}.
• Choosing a treatment strategy: There are different approaches to treatment. Some doctors start with moderate-efficacy therapies and escalate to stronger drugs only if the MS remains active. However, observational data suggests that starting early with higher-efficacy therapies (treatments that tend to suppress MS activity more strongly) may offer better long-term protection against relapses and new lesions ^{[8] [9] [10]}. Higher-efficacy drugs are not proven superior for everyone, and they often require greater safety monitoring, making this strategy an individualized choice.

Your Baseline Checklist: What to Do Before Your First Dose

While prompt treatment planning matters, it is reasonable to take the time needed for a safe start unless your team identifies urgent disease activity. Each medication has specific requirements.

• Baseline Laboratory Tests: You will likely need tests to check your liver function and white blood cell counts to establish a starting point (baseline) ^[11].
• Medication-Specific Screening: Because DMTs affect your immune system, your doctor will order tests tailored to the specific drug you are considering. For example, some drugs require screening for Hepatitis B or Tuberculosis ^[12]. Others require testing for antibodies to the John Cunningham (JC) virus ^[13]. The JCV test is not looking for a hidden active infection; it checks for prior exposure to help estimate the risk of a rare brain infection called progressive multifocal leukoencephalopathy (PML), particularly if you take a drug called natalizumab ^[13].
• Vaccinations: You should update your routine vaccines—such as the non-live flu shot, COVID-19, or recombinant shingles vaccine—before starting a DMT ^{[12] [14]}. Some DMTs can reduce how well your body responds to vaccines ^[15]. Live vaccines often require a longer waiting period and may be unsafe once treatment starts ^{[12] [16]}. Follow the specific schedule designed by your clinician, and do not unnecessarily delay urgent treatment without medical advice ^[17].

Shared Decision-Making: Choosing the Right Time and Drug

The choice of DMT depends on a conversation between you and your neurologist about your disease activity, other health conditions, and personal preferences ^[7]. Key factors include:

• Family Planning: If you are planning to become pregnant, this will heavily influence your drug choice. Some medications must be stopped (washed out) well before conception, while others can be continued or managed carefully ^[18]. Never stop a DMT on your own if you become pregnant. Your team will also plan for the postpartum period (the time immediately after giving birth), when the risk of an MS relapse naturally increases ^[19]. With certain drugs, stopping treatment abruptly can lead to a rebound relapse—a rapid, severe return of MS activity ^{[18] [19]}.
• Monitoring and Administration: You will weigh the convenience of how the drug is taken (daily pills, occasional infusions, or at-home injections) against its potential side effects and required follow-up MRIs and blood tests ^{[7] [20]}.